Clinical and hematological study for Parvovirus b19 infection in children with acute leukemia

International Journal of Laboratory Hematology

Volumn 32, Issue 2, 2010, Pages 159-166

  Zaki, M E S ^a   Ashray, R E ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Acute leukemia; Children; Cytopenia; Microbiology; Parvovirus B19

Indexed keywords

CYTARABINE; DAUNORUBICIN; DNA ANTIBODY; GLUCOCORTICOID; HEMOGLOBIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MERCAPTOPURINE; METHOTREXATE; VINCRISTINE; VIRUS DNA;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADD ON THERAPY; ADOLESCENT; ARTICLE; CANCER CHEMOTHERAPY; CHILD; CLINICAL FEATURE; CLINICAL STUDY; CONTROLLED STUDY; CYTOPENIA; DRUG MEGADOSE; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMA INFECTIOSUM; FEMALE; HEMATOLOGICAL PARAMETERS; HEMOGLOBIN BLOOD LEVEL; HEPATOSPLENOMEGALY; HUMAN; INFANT; LYMPHADENOPATHY; LYMPHOCYTOSIS; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; NONHUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; STATISTICAL SIGNIFICANCE; THROMBOCYTOPENIA;

ADOLESCENT; ANTIBODIES, VIRAL; ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMATOLOGIC TESTS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LABORATORY TECHNIQUES AND PROCEDURES; LEUKEMIA; MALE; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; POLYMERASE CHAIN REACTION;

EID: 77953599676     PISSN: 17515521     EISSN: 1751553X     Source Type: Journal    
DOI: 10.1111/j.1751-553X.2009.01150.x     Document Type: Article

References (26)

1. Anderson L.J. (2002) Human parvovirus B19. In: Clinical Virology (eds D.D. Richman, J.R. Whitley & F.G. Hayden), pp. 2036-2094. ASSN Press, Washington DC.
2. Ashan N., Holman M.J., Gocke C.D., Groff J.A. & Yang H.C. (1997) Pure red cell aplasia due to parvovirus B19 infection in solid organ transplantation. Clinical Transplantation 11, 265-270.
3. Brown K.E. (2000) Hematological consequences of Parvovirus B19 infection. Baillière's Best Practice & Research. Clinical Haematology 13, 245-259.
4. Brown K.E., Anderson S.M. & Young N.S. (1993) Erythrocyte P antigen cellular receptor of parvovirus B19. Science 268, 114-117.
5. Chermak E., Dubin G., Henry D., Naides S.J., Hodinka R.L., MacGregor R.R. & Friedman H.M. (1995) Infection due to parvovirus B19 in patients with human immunodeficiency virus. CID 20, 170-173.
6. Childhood ALL Collaborative Group. (1996) Duration and intensity of maintenance chemotherapy in acute lymphoblastic leukaemia: overview of 42 trials involving 12000 randomised children. Lancet 347, 1783-1788.
7. Clewley J.P. (1989). Polymerase chain reaction assay of parvovirus B19 DNA in clinical specimens. Journal of Clinical Microbiology 27/12: 2647-2651.
8. Cooling L.L.W., Zhang D.S., Naides S.J. & Koerner T.A.W. (2003) Glycosphingolipid expression in acute nonlymphocytic leukemia: common expression of Shiga toxin and parvovirus B19 receptors on early myeloblasts. Blood 101, 711-721.
9. Fattet S., Cassinotti P. & Popovic M.B. (2004) Persistent Human Parvovirus B19 Infection in Children Under Maintenance Chemotherapy for Acute Lymphocytic Leukemia. Journal of Pediatric Hematology/Oncology 26, 497-503.
10. Flunker G., Peters A., Wiersbitzky S., Modrow S. & Seidel W. (1998) Persistent parvovirus B19 infection in immunocompromised children. Medical Microbiology and Immunology 186, 189-194.
11. Gautier E., Bourhis J.H., Bayle C., Cartron J., Pico J.L. & Tchernia G. (1997) Parvovirus B19 associated neutropenia treatment with Rh G-CSF. Hematology and Cell Therapy 39, 85-87.
12. Harder C., Hufnagel M., Zahn K., Beutel K., Schmitt H.-J., Ullmann U. & Rautenberg P. (2001) New light cycler PCR for rapid and sensitive quantitation of parvovirus B19 DNA guides therapeutic decision making in relapsing infection. Journal of Clinical Microbiology 39, 4413-4419.
13. Heegaard E.D. & Brown K.E. (2002) Human Parvovirus B19. Clinical Microbiology Reviews 15, 485-505.
14. Heegaard E.D., Rasken C.J. & Christensen J. (2002) Detection of parvovirus B19 NS1 specific antibodies by ELISA & western blotting employing recombinant NS1 protein as antigen. Journal of Medical Virology 67, 375-383.
15. Kelly H., Siebert D., Hammond R., Leydon J., Kiely P. & Maskill W. (2000) The age-specific prevalence of human parvovirus immunity in Victoria, Australia, compared with other parts of the world. Epidemiology and Infection 124, 449-457.
16. Kerr J.R., Barah F., Cunniffe V.S., Smith J., Vallely P.J., Will A.M., Wynn R.F., Stevens R.F., Taylor G.M., Cleator G.M. & Eden O.B. (2003) Association of acute parvovirus B19 infection with new onset of acute lymphoblastic and myeloblastic leukaemia. Journal of Clinical Pathology 56, 873-875.
17. Knösel T., Meisel H., Borgmann A., Riebel T., Krenn V., Schewe C. & Petersen I. (2005) Parvovirus B19 infection associated with unilateral cervical lymphadenopathy, apoptotic sinus histiocytosis, and prolonged fatigue. Journal of Clinical Pathology 58, 872-875.
18. Lindblom A., Heyman M., Gustafsson I., Norbeck O., KaldensjöT., Vernby A., Henter J.I., Tolfvenstam T. & Broliden K. (2008) Parvovirus B19 infection in children with acute lymphoblastic leukemia is associated with cytopenia resulting in prolonged interruptions of chemotherapy. Clinical Infectious Disease 46, 528-536.
19. Mehraein Y., Wagner M., Remberger K., Füzesi L., Middel P., Kaptur S., Schmitt K. & Meese E. (2006) Parvovirus B19 detected in Rosai-Dorfman disease in nodal and extranodal manifestations. Journal of Clinical Pathology 59, 1320-1326.
20. Mihneva Z. (2005) Clinical manifestations, risks and trends regarding human Parvovirus B19 infection. Medical Review 41, 5-14.
21. Rao S.P., Miller S.T. & Coben B.J. (1994) B19 parvovirus infection in children with malignant solid tumours receiving chemotherapy. Medical and Pediatric Oncology 22, 255-257.
22. Schleuning M., Jager G., Holler E., Hill W., Thomssen C., Denzlinger C., Lorenz T., Ledderose G., Wilmanns W. & Kolb H.J. (1999) Human parvovirus B19 associated disease in bone marrow transplantation. Infection 27, 114-117.
23. Us T., Ozune L., Kasifoglu N. & Akgun Y. (2007) The investigation of parvovirus B19 infection in patients with hematological disorders by using PCR and ELISA techniques. The Brazilian Journal of Infectious Diseases 11, 327-330.
24. Wiemels J.L., Cazzaniga G., Daniotti M., Eden O.B., Addison G.M., Masera G., Saha V., Biondi A. & Greaves M.F. (1999) Prenatal origin of acute lymphoblastic leukaemia in children. Lancet 354, 1499-1503.
25. Yalcin A., Serin M.S., Emekdas G., Tiftik N., Aslan G., Eskandari G. & Tezcan S. (2009) Promoter methylation of P15 (INK4B) gene is possibly associated with parvovirus B19V infection in adult acute leukemias. International Journal of Laboratory Hematology 31, 407-419.
26. Yetgin S., Cetin M., Aslan D., Ozyurek E., Anlar B. & Uçkan D. (2004) Parvovirus B19 infection presenting as pre B-cell acute lymphoblastic leukaemia: a transient and progressive course in two children. Journal of Pediatric Hematology/Oncology 26, 689-692.